CROI 2017 Program and Information

Program and Agenda

437 PRO140 SINGLE-AGENTMAINTENANCE THERAPY FOR HIV-1 INFECTION: A 2-YEAR UPDATE Jay Lalezari 1 , Kush Dhody 2 , Ula Kowalczyk 1 , Kazem Kazempour 2 , Nader Pourhassan 3 , Paul J. Maddon 4 1 Quest Clinical Rsr, San Francisco, CA, USA, 2 Amarex Clinical Rsr, LLC, Germantown, MD, USA, 3 CytoDyn, Inc, Vancouver, WA, USA, 4 Maddon Advisors LLC, Scarsdale, NY, USA Themed Discussion TD-16 HOW DOES THE MICROBIOME AFFECT HIV INFECTION? Room 6 E 1:30 PM - 2:30 PM Themed Discussion Leader Cara Wilson, MD , Univ of Colorado-Anschutz Medical Campus, Aurora, CO, USA 207 IMPACT OFMSM-ASSOCIATEDMICROBIOTA ON IMMUNE ACTIVATION AND INVITRO HIV INFECTION Sam Li , Abigail Armstrong, Charles P. Neff, Catherine Lozupone, Brent E. Palmer Univ of Colorado, Aurora, CO, USA 208 FECALMICROBIOTA FROMHIV-INFECTED SUBJECTS INCREASES IMMUNE ACTIVATION AND INFECTION Charles P. Neff , Sam Li, Abigail Armstrong, Catherine Lozupone, Brent E. Palmer Univ of Colorado, Aurora, CO, USA 209 MARAVIROC INHIBITS HIV TARGET T-CELL TRAFFICKING INTO THE FEMALE GENITAL LUMEN Alison S. Kohlmeier 1 , Sean McMaster 2 , Jessica Radzio 1 , Mian-er Cong 1 , Chuong Dinh 1 , Amy Martin 1 , Jacob E. Kohlmeier 2 , Gerardo Garcia-Lerma 1 1 CDC, Atlanta, GA, USA, 2 Emory Univ, Atlanta, GA, USA 210 INVESTIGATING THE EFFECT OF PH ON CERVICOVAGINALMUCUS BARRIER PROPERTIES TO HIV Julie K. Shade , Thuy Hoang, Kevin Delong, Justin Hanes, Richard Cone, Laura Ensign The Johns Hopkins Univ, Baltimore, MD, USA Themed Discussion Leader Robert T. Schooley , Univ of California San Diego, La Jolla, CA, USA 1054 CHARACTERIZATION OFMORE THAN10,000 ZIKA VIRUS TEST RESULTS IN THE US Joseph M. Volpe 1 , Dajie Luo 1 , Arren Fisher 1 , Mindy Nye 2 , Barbara Body 2 , Marcia Eisenberg 1 1 LabCorp, Durham, NC, USA, 2 LabCorp, Burlington, NC, USA 1055LB ZIKA VIRUS PERSISTENCE IN BODY FLUIDS Gabriela Paz-Bailey 1 , Eli Rosenberg 2 , Katherine Doyle 1 , Jorge Munoz- Jordan 1 , Gilberto Santiago 1 , Liore Klein 3 , Janice Perez 1 , Stephen Waterman 1 , Luisa Alvarado 4 , Tyler Sharp 1 1 CDC, Atlanta, GA, USA, 2 Emory Univ, Atlanta, GA, USA, 3 Caduceus Healthcare, Inc, Ponce, PR, USA, 4 Ponce Univ, Ponce, PR, USA Themed Discussion TD-17 EMERGING VIRUSES: THE ZIKA VIRUS Room 6 AB 1:30 PM - 2:30 PM

Oral Sessions • Thursday

CROI 2017 69